Top Markets
Coin of the day
MaaT Pharma S.A. MaaT Pharma S.A.

MaaT Pharma S.A.

MAAT
Classifica tra le azioni #23616
MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on... MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on the discovery and advancement of microbiome-based biotherapies, primarily for the treatment of solid cancer tumors. Its development pipeline features MaaT013, which has successfully completed Phase 2 clinical trials for acute graft-versus-host disease (aGVHD) and is also undergoing preclinical evaluation for melanoma. Another therapeutic candidate, MaaT033, is currently in Phase 1b clinical trials, aiming to improve survival outcomes for patients with acute myeloid leukemia (AML) or other liquid malignancies following allogeneic hematopoietic stem cell transplantation. Furthermore, MaaT03X is being developed specifically for solid tumor applications. The company was founded in 2014 and maintains its headquarters in Lyon, France.
Prezzo delle azioni
$3.78
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$71.20M
Variazione (1 giorno)
2.24%
Variazione (1 anno)
-43.37%
Paese
FR
Scambia MaaT Pharma S.A. (MAAT)

Categoria

Storico del prezzo dell'azione per MaaT Pharma S.A. (MAAT)
Prezzo di chiusura più alto: $3.53 il 2026-08-01

Prezzo di chiusura più basso: $15.22 il 2021-11-01
Storico del prezzo dell'azione di MaaT Pharma S.A. dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 10.63%
2025 -39.72%
2024 11.45%
2023 -18.97%
2022 -38.00%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH